CODX vs NKE · rev $3.9M vs P/E 35, rev $46.31B
Co-Diagnostics, Inc. Common Stock (CODX) versus Nike Inc (NKE) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported NKE revenue for 2025-05-31 was $46.31B. Net income was $3.22B. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
CODX currently screens at market cap $31.4M. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
Not investment advice. Open the CODX and NKE stock pages for the full models.
Not investment advice.